04668nam 2201201z- 450 991055714200332120231214133100.0(CKB)5400000000040638(oapen)https://directory.doabooks.org/handle/20.500.12854/68385(EXLCZ)99540000000004063820202105d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierDiagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0Basel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 electronic resource (240 p.)3-03943-685-6 3-03943-686-4 After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer.MedicinebicsscMetallothioneinurotheliumurothelial cancercadmium exposurezinc transporterbladderTAGLNF-actinPTENp53tumorigenesisproliferationinvasionTERT promoter mutationsFGFR3non muscle invasive bladder cancerBCG therapybladder cancerJAK-STAT pathwaycombination therapyoncolytic adenovirusvirotherapySTAT3/5 inhibitorJAK inhibitorXVir-N-31bladder cancer detectionurinary biomarkersDNA methylationECRG4ITIH5biomarkercancergrademetabolomicsMSNMRbiomarkerstumor markersprognosisheparanasesyndecan-1heparan sulfate proteoglycans (HSPGs)urothelial carcinomamiRNAquantitative PCRtumor markervoided urine cytologyKDM7Ahistone demethylaseTC-E 5002androgen receptordrug resistancenon-invasive detectiontelomerasesomatic mutationsTERT promoter regionmuscle-invasive bladder cancerchemotherapyimmunotherapypersonalized medicinepredictive biomarkersurvivinBIRC5macrophageKRT20ERBB2MIBCpredictionRT-qPCRadjuvant chemotherapysurvivalMedicineEcke Thorstenedt1313317Otto ThomasedtEcke ThorstenothOtto ThomasothBOOK9910557142003321Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer – Illumination of a Vision 2.03031280UNINA